NEW YORK, April 24, 2025 /PRNewswire/ — SeeTrue Screening Ltd announces that the SeeTrue X-ray threat detection software has completed operational test and evaluation by National Safe Skies Alliance, Inc. (Safe Skies) at Seattle–Tacoma International Airport. Read...
Read MoreSAN FRANCISCO, April 29, 2025 /PRNewswire/ — Appdome, the leader in protecting mobile businesses, today announced at RSAC 2025 that its AI-Native MobileBOT™ Defense solution now offers the most comprehensive mobile bot defense profile on the market. Capable of evaluating 400+ attack vectors in Android & iOS apps, OSs, devices, user interfaces and networks, Appdome’s new MobileBOT™ defense profile allows network security teams to not only stop brute force bot and credential stuffing attacks but also stop hyper targeted, spear phishing, account takeover (ATO), KYC fraud, on-device fraud (ODF), and deepfake threats in real time across account creation, login, password reset, payment and other critical API endpoints. Read...
Read MoreNEW YORK, April 29, 2025 /PRNewswire/ — Ro, the leading direct-to-patient telehealth company, today announced that NBA Hall of Famer and five-time Sports Emmy Award winning broadcaster Charles Barkley is joining on as a GLP-1 celebrity ambassador. The partnership is deeply personal for Barkley, who is restarting his weight loss journey with Ro after facing significant barriers to treatment access and weight regain. Read...
Read MoreMOUNTAIN VIEW, Calif., April 29, 2025 /PRNewswire/ — Groq, a leader in AI inference, announced today its partnership with Meta to deliver fast inference for the official Llama API – giving developers the fastest, most cost-effective way to run the latest Llama models. Read...
Read MoreNEW YORK, April 29, 2025 /PRNewswire/ — Ro today announced an integration with NovoCare® Pharmacy to provide seamless access to all doses of Wegovy® at the best available cash price of $499 per month. By working directly with Novo Nordisk’s direct-to-patient option NovoCare® Pharmacy, Ro ensures patients have a reliable supply of FDA-approved GLP-1 medication directly from the manufacturer. With Ro’s streamlined experience, patients can consult with a provider and get access to effective GLP-1 medication at the lowest cash price, without ever having to leave the Ro app. Read...
Read More
